Disposable Pain Pumps Market - Forecast (2022 - 2027)

Disposable Pain Pumps Market size is estimated to reach $421.4 million by 2027, growing at a CAGR of 5.2% during the forecast period 2022-2027. Pain pumps or intrathecal drug delivery is a technique of delivering medication like an opioid directly to the spinal cord. The system includes a tiny pump that is surgically positioned under the abdominal skin that delivers the medicine by way of a catheter to the area around the spinal cord. Pain pumps are typically advised if all other conventional techniques have failed to offer alleviation from long-term symptoms. As the medication is delivered directly to the spinal cord, the quantity of dose needed is much smaller than is required with oral medicine. AutoFuser ® Disposable Pain Pumps developed by Teleflex Medical provide a combination of a continuous hands-free infusion with an optional on-demand patient-controlled bolus planned to instantly attend to breakthrough pain. Intrathecal pumps are tiny medical devices, that convey medicines directly to the spinal cord, into the intrathecal space. An external infusion pump is a medical device utilized to transfer liquids into the body of a patient in a controlled manner. There are numerous distinct kinds of infusion pumps, which are utilized for an array of purposes and in an assortment of environments. Pressure-driven flows are produced by syringe pumps which permit molecules transported in a liquid stream and diffused all through the microchannel. Implantable pumps include reservoirs, positioned subcutaneously, which link through a catheter into the intrathecal space. Implantable pumps permit physicians to apply opiate analgesics directly into the cerebrospinal fluid (CSF). The pumps are programmable so that the treating physicians can regulate dosages and delivery rates. Insulin pumps are tiny, computerized devices that imitate the way the human pancreas performs by transferring tiny doses of short-acting insulin continuously (basal rate).

The considerable decrease in pain brought about by reflex sympathetic dystrophy and cancer and the increasing application of insulin pumps by diabetics are set to drive the Disposable Pain Pumps Market. The enhanced quality of life owing to the capability to carry out daily routine activities, reduced medication of dose, security and efficiency, and ease of device evacuation is set to propel the growth of the Disposable Pain Pumps Market during the forecast period 2022-2027. This represents the Disposable Pain Pumps Industry Outlook.

Report Coverage

The report: “Disposable Pain Pumps Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Disposable Pain Pumps Market.

By Type: < 200 ml, 200 – 400 ml, 400 – 600 ml, > 600 ml.
By End User: Hospitals, Clinics, Others.
By Geography: North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Key Takeaways

• Geographically, North America Disposable Pain Pumps Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the surging trends in clinical practice, guidelines and protocols, and the rising application of insulin pumps by diabetics in the North American region.
• Disposable Pain Pumps Market growth is being driven by the vital decrease in pain brought about by failed back surgery syndrome, the proliferating application of insulin pumps by diabetics, and current approvals by the U.S. Food And Drug Administration (FDA). However, surgical complexities like infections, side effects, spinal fluid leak resulting in headache, and happening of inflammatory mass at the tip of the catheter breakdown of device owing to collapse of crucial parts, constituents or battery are some of the major factors hampering the growth of Disposable Pain Pumps Market. 
• Disposable Pain Pumps Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Disposable Pain Pumps Market report. 

Disposable Pain Pumps Market Segment Analysis – By Type

The Disposable Pain Pumps Market based on type can be further segmented into < 200 ml, 200 – 400 ml, 400 – 600 ml, and > 600 ml. The < 200 ml Segment held the largest market share in 2021. This growth is owing to the surging application of disposable pain pumps to efficiently manage post-operative pain. Intrathecal pumps are a progressive technique for managing chronic back pain. The soaring benefits experienced by chronic pain patients like decreased pain, the overall enhancement in activities of day-to-day living, and patients with spasticity observing diminished rigidity and muscle spasms are further propelling the growth of the < 200 ml segment.

Furthermore, the 200 – 400 ml segment is estimated to grow with the fastest CAGR of 6.5% during the forecast period 2022-2027 owing to the heightening application of pain pumps like ON-Q* PAIN RELIEF SYSTEM, PUMP WITH FIXED FLOW RATE, 400 ML, 8 ML/HR for automatically and continuously transferring a regulated flow of local anesthetic to a patient’s surgical site or in close proximity to nerves, offering targeted pain relief for up to 3-5 days with infusion pumps being extensively utilized for infusing liquids, medicine or nutrients into the circulatory system of a patient.

Disposable Pain Pumps Market Segment Analysis – By End User

The Disposable Pain Pumps Market based on end user can be further segmented into Hospitals, Clinics and Others. The Hospitals Segment held the largest market share in 2021. This growth is owing to the surging application of disposable pain pumps to treat chronic pain post the increasing count of surgeries endured by an enormous pool of patients in hospitals. Intrathecal pumps are widely utilized to treat chronic pain attributed to failed back surgery syndrome. The burgeoning count of hospitals together with sufficient reimbursement policies, progressive infrastructure, and sufficient facilities are further propelling the growth of this segment.

Furthermore, the Clinics segment is estimated to grow with the fastest CAGR of 6.9% during the forecast period 2022-2027 owing to the extensive application of disposable infusion pumps inclusive of patient-controlled analgesia (PCA) pumps, patient-controlled epidural analgesia, continuous peripheral analgesia, continuous epidural analgesia, continuous i.v. analgesia, and paediatrics applications.

Disposable Pain Pumps Market Segment Analysis – By Geography

The Disposable Pain Pumps Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (Disposable Pain Pumps Market) held the largest share with 35% of the overall market in 2021. The growth of this region is owing to the increasing predominance of incessant pain following surgery and the burgeoning pervasiveness of spinal cord injuries in the North American region. Intrathecal pumps are extensively utilized in the treatment of chronic pain owing to failed back surgery syndrome. The enhanced nurse education and coaching, progressive healthcare facilities, and heightening focus on minimally invasive methods for pain management are further propelling the growth of the Disposable Pain Pumps Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the surging demand for superior pain management devices like intrathecal pumps in the Asia-Pacific region. The expanding population of the elderly and the soaring accessibility of pain pumps are further fuelling the progress of the Disposable Pain Pumps Market in the Asia-Pacific region.

Disposable Pain Pumps Market Drivers

Surging Applications of Intrathecal Pumps are Projected to Drive the Growth of Disposable Pain Pumps Market:

Intrathecal pain pumps or intrathecal pumps are implantable devices including reservoirs and medical tubings that convey precise doses of medication directly to the spinal cord. There are two pain pump alternatives: fixed-rate pumps and variable-rate pumps. Fixed-rate pumps convey a steady stream of pain medicine into the spine, and variable-rate pumps are programmed to offer the quantity of medication required at the right times to fulfill particular requirements. Intrathecal pain pumps can deliver different medications into the spine. Morphine, hydromorphone, baclofen, and ziconotide are certain most typically prescribed medications. Physicians recommend that intrathecal pumps may be utilized to alleviate chronic pain, failed back surgery syndrome, cancer-associated pain, complex regional pain syndrome (CRPS), and more. In the inpatient setting, intrathecal pump rises are at times made as frequently as every 12 hours (versus every 24 hours in an outpatient setting), and the rate routinely can be conservatively raised up to 15% if nonopioids are in the pump and up to 20% if the pump includes only opioids. A typical guideline is to provide 5% to 10% of the patient's everyday dose every 4 to 8 hours as required (as rapidly as over 10 to 15 minutes with opioids only in the pump and over 40 or more minutes if the pump includes numerous medications). The surging applications of intrathecal pumps are therefore fuelling the growth of the Disposable Pain Pumps Market during the forecast period 2022-2027.

Soaring Significance of Disposable Infusion Pumps are Expected to Boost the Growth of the Disposable Pain Pumps Market:

All non-electric disposable infusion pumps take advantage of the identical physical principle: mechanical restriction within the flow path decides the speed of pressurized liquid. The pressure produced by disposable pumps on the fluid is 250-600 mm Hg, in comparison with 5-1200 mm Hg of pressure for electric pumps. There are numerous kinds of disposable infusion pumps, inclusive elastomeric, positive-pressure (spring-powered and gas-pressure-powered), negative-pressure (vacuum), and patient-controlled analgesia (PCA) pumps. The accuracy of the flow rate of every pump is reliant on numerous determinants, inclusive of temperature, fluid viscosity, atmospheric pressure, back pressure, partial filling, and storage. Disposable infusion pumps can be utilized in multiple areas, inclusive of home care, PCA, patient-controlled epidural analgesia, continuous peripheral analgesia, continuous epidural analgesia, and continuous i.v. analgesia, and paediatrics applications. The benefits of disposable infusion pumps involve their reduced weight, tiny size, simplicity of application, independence from an external power supply, removal of programming errors, and disposability. The soaring significance of disposable infusion pumps is therefore driving the growth of the Disposable Pain Pumps Market during the forecast period 2022-2027.

Disposable Pain Pumps Market Challenges

Risks of Managing Pain with Patient-Controlled Analgesia (PCA) Pumps are Hampering the Growth of the Disposable Pain Pumps Market:

Greater than 70 million patients undergo surgery each year in the U.S., of which 80% endure acute postoperative pain, with 20% enduring serious pain. Patient-controlled analgesia (PCA) pumps have been demonstrated to be more efficient in treating pain than intermittent intramuscular or intravenous injections. The possibility of accepting excessive medicine may happen. This can occur in two ways: (1) if the physician commands too powerful of a dose of the Morphine or the Dilaudid or (2) if the nurse who is arranging the machinery programs the machine with an erroneous concentration or an improper dose and no one double checks that and spots the error. An issue that there has been trouble with in the past is whether there needs to be a continuous infusion of the pain medicine over a period of time and that was termed a basal rate and it is no longer typical. Therefore, in other words, what physicians used to do was to command that a patient would accept a continued infusion of Morphine, for example, 5 milligrams per hour. Then when the patient pushed the button, the patient would accept an added dose of Morphine. This resulted in the over-sedation of patients. The current trend is thus to halt the command of continuous infusion and only have the pump set so that it will offer medicine when the patient pushes the button. Injury and demise can happen even if there are no errors associated with the programming or application of the patient-controlled analgesia (PCA) pump. Depending upon oximetry and nurse evaluations are not adequate. Continued electronic monitoring of patients utilizing patient-controlled analgesia (PCA) pumps with oximetry for oxygenation and capnography for sufficiency of ventilation offers a technological safety net for attending caregivers. These issues are thus hampering the growth of the Disposable Pain Pumps Market.

Disposable Pain Pumps Industry Outlook

Product launches, technological innovations, mergers and acquisitions, partnerships and collaborations are key strategies adopted by players in the Disposable Pain Pumps Market. Key companies of this market are:

1. Teleflex
2. AMBU Inc.
3. Moog Inc.
4. Grobir Medical Suppliers
5. I-Flow Corp.
6. McKinley Medical LLLP.
7. Orthofix International
8. NVSgarlato Laboratories
9. Sorenson Medical Inc.
10. Stryker Corp.

Recent Developments:

• In May 2021, Baxter International Inc. declared the worldwide introduction of PrisMax2, the latest version of the firm’s next-generation platform. PrisMax 2 is planned to assist in simplifying the delivery of continuous renal replacement therapy (CRRT) and other organ support therapies while offering hospitals the flexibility to meet the rare demands of the intensive care unit (ICU). The PrisMax 2 system is characterized by novel solutions within the company’s TrueVue digital health portfolio, as well as the PrismaLung+ blood-gas exchanger that delivers extracorporeal carbon dioxide elimination (ECCO2R) therapy to back the management of acute respiratory dysfunction.
• In February 2021, Medical device company C2Dx Inc. gained the T/Pump product line from Stryker Corp. Both firms are based in Kalamazoo, which has evolved into a medical technology powerhouse emphasized by the COVID-19 vaccine being generated by Pfizer. Kalamazoo also is home to numerous medical technology parks, Western Michigan University, and is a big manufacturer of medical devices and numerous pharmaceuticals.

Related Reports

Infusion Therapy Devices Market - Forecast(2022 - 2027)

Report Code: HCR 0011

Variable Displacement Pumps Market - Forecast(2022 - 2027)

Report Code: CMR 0701

LATAM Infusion Therapy Devices Market - Forecast(2022 - 2027)

Report Code: HCR 1309

 For more Lifesciences and Healthcare Market reports, please click here